Innovative Approach to Detect Recurrent Colorectal Lesions With Surveillance Via Mutation Analysis & Clinical Phenotype

Recruiting Observational Study
Predictive Cancer Model
Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 75
Sex
Any
Study type
Observational
Participants needed
200 (estimated)
Sponsor
Military University Hospital, Prague · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
It is known that the development of colorectal adenoma is dependent on the appearance of somatic mutations in protooncogenes and tumor suppressor genes. Based on our previous mutation analyses of 120 patients with high-risk adenoma removed by enbloc resection with subsequent colonoscopy after 1 year, there is a correlation between mutation in exon 7 of the TP53 gene and risk of early metachronous …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Colorectal polyp larger than 10mm removed by colonoscopy therapeutic method (EPE, EMR, ESD) * Signed informed consent with the study and with colonoscopy Exclusion Criteria: * FAP, HNPCC and other hereditary CRC syndromes probands * Colonoscopy contraindication * Severe acut…
Contacts

Stepan Suchanek, assoc. prof.

973208367

stepan.suchanek@uvn.cz

CONTACT

Tomas Grega, MD, Ph.D.

973203076

tomas.grega@uvn.cz

CONTACT